We are live on ! Find out more
WSC

White Square Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 151.72%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+151.72%
3 Year Est. Return
+541.98%
5 Year Est. Return
10 Year Est. Return
AUM
$70.8M
AUM Growth
-$167M
Cap. Flow
-$170M
Cap. Flow %
-240.25%
Top 10 Hldgs %
100%
Holding
9
New
Increased
1
Reduced
Closed
8

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 100%
2 Consumer Discretionary 0%
3 Financials 0%
4 Healthcare 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
1
NXP Semiconductors
NXPI
$57.4B
$70.8M 100%
646,670
+151,353
+31% +$16.2M
CP icon
2
Canadian Pacific Kansas City
CP
$80.7B
-108,920
Closed -$3.2M
NSC icon
3
Norfolk Southern
NSC
$74B
-26,438
Closed -$2.96M
UNP icon
4
Union Pacific
UNP
$173B
-29,699
Closed -$3.15M
GBT
5
DELISTED
Global Blood Therapeutics, Inc.
GBT
-1,454,365
Closed -$53.6M
KSU
6
DELISTED
Kansas City Southern
KSU
-36,398
Closed -$3.12M
TSRO
7
DELISTED
TESARO, Inc.
TSRO
-95,627
Closed -$14.7M
CBF
8
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
-1,204,339
Closed -$52.3M
KATE
9
DELISTED
Kate Spade & Company
KATE
-2,292,259
Closed -$53.2M

Similar funds

White Square Capital's Q2 2017 Portfolio in Review

As of Q2 2017, White Square Capital held 9 positions worth $70.8M, down 70% from $238M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

White Square Capital withdrew a net $170M in Q2 2017, closing 8 positions. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 100% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, White Square Capital added an estimated $16.2M to NXP Semiconductors.

  • White Square Capital added most to NXP Semiconductors in Q2 2017, an estimated $16.2M increase.
  • White Square Capital fully exited Global Blood Therapeutics, Inc. in Q2 2017, selling an estimated $53.6M.
  • White Square Capital's ten largest holdings make up 100% of its $70.8M portfolio in Q2 2017.
  • White Square Capital opened 0 new positions and closed 8 in Q2 2017.
  • White Square Capital's portfolio value fell 70% quarter-over-quarter to $70.8M.

Based on White Square Capital's 13F filing for Q2 2017, filed 11 Aug 2017.